top of page

Topic

Liver Cancer

20 Podcasts • 6 Cases • 3 Courses on BackTable

Hear how experienced physicians manage Liver Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 673  •  08 Sept 2026

Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study

The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can tolerate, where to deliver it, and when to safely push the dose. In this episode of the BackTable Podcast, Drs. Tyler Sandow and Ryan Hickey join host Dr. Kavi Krishnasamy to explore strategies for using Y90 in hepatocellular carcinoma and liver metastases. They combine real-world data from a study of nearly 1,000 patients with insights into methodology and the many variables that influence these procedures.

This podcast is supported by an educational grant from Boston Scientific TheraSphere Y-90.

More on Liver Cancer

Loading recent podcasts…

VI

Vascular & IR # 673

Sep 7, 2026

with Dr. Ryan Hickey, Dr. Tyler Sandow, Dr. Venkatesh Krishnasamy

Y90 for Liver-Directed Cancer Treatments: The PROACTIF Study

The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can...

1,900+ listens

Tumor Board

Tumor Board # 58

May 4, 2026

with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi

Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options

When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...

​

VI

Vascular & IR # 639

Apr 29, 2026

with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes, Dr. Venkatesh Krishnasamy

Advancements in Ablation Techniques for Liver Tumors

Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence?...

​

VI

Vascular & IR # 632

Apr 7, 2026

with Dr. Riad Salem, Dr. Tyler Sandow, Dr. Juan Gimenez

Career Choices That Work & Those That Don't Work

You may know him as the godfather of Y90, but you might not know what it took for Dr. Riad Salem to earn that title....

​

Tumor Board

Tumor Board # 59

May 11, 2026

with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...

​

VI

Vascular & IR # 640

Apr 30, 2026

with Dr. Maarten Smits, Dr. Venkatesh Krishnasamy

Hepatic Arteriography & C-Arm CT-Guided Liver Ablation

When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In...

1,700+ listens

Tumor Board

Tumor Board # 57

Apr 27, 2026

with Dr. Lingling Du, Dr. Craig Lockhart, Dr. Jonathan Mizrahi

First-Line Therapy for Advanced Hepatocellular Carcinoma: Decisions in the Real World

Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In...

​

VI

Vascular & IR # 577

Sep 29, 2025

with Dr. Driss Raissi, Dr. Christopher Beck

Microwave Ablation for Liver Tumors: Techniques & Outcomes

Is microwave ablation only for simple liver tumors, or can it be a versatile ‘Swiss Army knife’ for a wide range of...

2,100+ listens

VI

VI Case

Jul 27, 2026

BRTO/PARTO to Manage High Lung Shunt Fraction Prior to Y90 for HCC

with Dr. Trushar Patel and Dr. Sabeen Dhand

VI

VI Case

Apr 30, 2026

Liver Ablation: Evaluating Margins with Cone Beam CT Fusion Software in Hepatic Malignancies

with Dr. Maarten Smits and Dr. Venkatesh Krishnasamy

VI

VI Case

Apr 29, 2026

Liver Ablation: Switching from Y90 to Cryoablation to Treat an LR-5 HCC Tumor

with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes and Dr. Venkatesh Krishnasamy

VI

VI Case

Apr 29, 2026

HCC: Ablation in 76-Year Old Male with Small HCC, Poor Visibility on CT

with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes and Dr. Venkatesh Krishnasamy

VI

VI Case

Apr 8, 2026

HCC: 4.8 cm HCC Lesion in Segment 7, Locoregional Therapy or Surgical Resection?

with Dr. Riad Salem, Dr. Neil Mehta and Dr. Tyler Sandow

Endovascular Management of HCC

VI Course

2 hours, 37 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page